The role of cellular metabolism in regulating cell proliferation and differentiation remains poorly understood 1 . For example, most mammalian cells cannot proliferate without exogenous glutamine supplementation even though glutamine is a non-essential amino acid 1,2 . Here we show that mouse embryonic stem (ES) cells grown under conditions that maintain naive pluripotency 3 are capable of proliferation in the absence of exogenous glutamine. Despite this, ES cells consume high levels of exogenous glutamine when the metabolite is available. In comparison to more differentiated cells, naive ES cells utilize both glucose and glutamine catabolism to maintain a high level of intracellular a-ketoglutarate (aKG). Consequently, naive ES cells exhibit an elevated aKG to succinate ratio that promotes histone/ DNA demethylation and maintains pluripotency. Direct manipulation of the intracellular aKG/succinate ratio is sufficient to regulate multiple chromatin modifications, including H3K27me3 and teneleven translocation (Tet)-dependent DNA demethylation, which contribute to the regulation of pluripotency-associated gene expression. In vitro, supplementation with cell-permeable aKG directly supports ES-cell self-renewal while cell-permeable succinate promotes differentiation. This work reveals that intracellular aKG/succinate levels can contribute to the maintenance of cellular identity and have a mechanistic role in the transcriptional and epigenetic state of stem cells.
The role of cellular metabolism in regulating cell proliferation and differentiation remains poorly understood 1 . For example, most mammalian cells cannot proliferate without exogenous glutamine supplementation even though glutamine is a non-essential amino acid 1, 2 .
Here we show that mouse embryonic stem (ES) cells grown under conditions that maintain naive pluripotency 3 are capable of proliferation in the absence of exogenous glutamine. Despite this, ES cells consume high levels of exogenous glutamine when the metabolite is available. In comparison to more differentiated cells, naive ES cells utilize both glucose and glutamine catabolism to maintain a high level of intracellular a-ketoglutarate (aKG). Consequently, naive ES cells exhibit an elevated aKG to succinate ratio that promotes histone/ DNA demethylation and maintains pluripotency. Direct manipulation of the intracellular aKG/succinate ratio is sufficient to regulate multiple chromatin modifications, including H3K27me3 and teneleven translocation (Tet)-dependent DNA demethylation, which contribute to the regulation of pluripotency-associated gene expression. In vitro, supplementation with cell-permeable aKG directly supports ES-cell self-renewal while cell-permeable succinate promotes differentiation. This work reveals that intracellular aKG/succinate levels can contribute to the maintenance of cellular identity and have a mechanistic role in the transcriptional and epigenetic state of stem cells.
Mouse ES cells can be maintained in two medium formulations: a serum-free medium reported to support a cellular phenotype that mimics 'naive' epiblast cells of the inner cell mass (containing GSK-3b and MAPK/ ERK inhibitors (2i)/leukaemia inhibitory factor (LIF), hereafter 2i/L); or a serum-based medium that supports the proliferation of a more committed ES cell phenotype (serum/LIF, hereafter S/L) [4] [5] [6] [7] [8] [9] [10] [11] . To characterize ES cell metabolism, we investigated whether cells cultured in these two media have different requirements for glucose and/or glutamine. ES cells cultured in either medium proliferated at equivalent rates when glucose and glutamine were abundant and cells cultured with or without 2i were unable to proliferate in the absence of glucose (Extended Data Fig. 1a, b) . In contrast, cells cultured in 2i/L, but not S/L, proliferated robustly in the absence of exogenous glutamine ( Fig. 1a and Extended Data Fig. 1c ). Likewise, four newly derived ES-cell lines (ESC-1-4) exhibited convincing glutamine-independent proliferation in 2i/L medium while retaining features of pluripotent cells, including ES-cell-like morphology, reactivity to alkaline phosphatase (AP) and the ability to form teratomas (Fig. 1b, c and Extended Data Fig. 1d ). Cells cultured in 2i medium alone could also proliferate in the absence of exogenous glutamine (Extended Data Fig. 1e ).
This effect was not due to differences in medium nutrient formulations as supplementing S/L medium with the GSK-3b and MAPK/ERK inhibitors present in 2i also enabled glutamine-independent proliferation while maintaining ES cell morphology and markers of pluripotency ( Fig. 1d, e ). An alternative ES-cell medium containing BMP4 and LIF added to the same serum-free formulation as in 2i/L 12 failed to support glutamine-independent growth (Fig. 1f ). Likewise, epiblast stem cells (EpiSCs) could not proliferate in the absence of exogenous glutamine (Extended Data Fig. 1f, g) . However, the ability to undertake glutamineindependent growth was not limited to embryonic pluripotency; fibroblast-derived induced pluripotent cells (iPSCs) were also able to proliferate in glutamine-free 2i/L medium (Extended Data Fig. 1h ). These results indicate that the GSK-3b and MAPK/ERK inhibitors in 2icontaining medium are both necessary and sufficient to enable proliferation of pluripotent cells in the absence of exogenous glutamine.
The fact that cells proliferated in the absence of exogenous glutamine in 2i/L medium, albeit at a slower rate than cells cultured in glutaminereplete medium (Extended Data Fig. 1i ), indicates that these cells must be capable of de novo glutamine synthesis. Indeed, chemical inhibition of glutamine synthase was sufficient to block proliferation of cells in glutamine-free 2i/L medium (Extended Data Fig. 1j ). Likewise, addition of cell-permeable dimethyl-a-ketoglutarate (DM-aKG), a precursor for glutamine synthesis, was sufficient to enable glutamine-independent proliferation in both S/L and 2i/L conditions (Extended Data Fig. 1k ), suggesting that the supply of precursors for glutamine synthesis determines the ability of ES cells to proliferate in the absence of glutamine.
In support of this model, cells cultured in 2i/L preserved larger intracellular pools of glutamate after glutamine withdrawal than cells cultured in S/L ( Fig. 1g ). These results suggest that 2i/L cells can generate *These authors contributed equally to this work. glutamate (and glutamine) from carbon sources other than glutamine itself. Despite their different growth requirements, cells cultured in both S/L and 2i/L consumed high levels of glucose and glutamine and excreted similar levels of lactate, consistent with the metabolic profile of most proliferating cells, including cancer cells and pluripotent cells ( Fig. 2a) 1, 13 . Oxidation of glucose and glutamine via the mitochondrial tricarboxylic acid (TCA) cycle provides a critical source of the biosynthetic precursors required for cell proliferation. With the exception of aKG, steadystate levels of TCA cycle metabolites were reproducibly diminished in ES cells cultured in 2i/L (Fig. 2b) .
In most cells, glutamine is catabolized to aKG to support TCA cycle anaplerosis ( Fig. 2c ). ES cells grown in S/L medium exhibited high levels of TCA cycle intermediates and virtually all intracellular glutamate, aKG and malate were rapidly labelled after addition of [U-13 C]glutamine ( Fig. 2d) . In contrast, a substantial fraction of these metabolites failed to become labelled with glutamine in ES cells grown in 2i/L. Instead, there was a rapid labelling of these three metabolite pools from [U-13 C]glucose ( Fig. 2e ). Quantification of metabolite fluxes revealed that although the flux of glutamine-derived carbons through aKG was similar in both conditions, glutamine flux through malate was significantly diminished in cells cultured in 2i/L, indicating that the entry of glutamine-derived aKG into the TCA cycle is repressed by culture in 2i/L ( Fig. 2f ). Instead, when cells are cultured in 2i/L, a substantial amount of both aKG and malate was produced from glucose ( Fig. 2g ).
Consistent with these results, cells cultured with 2i inhibitors demonstrated substantial glucose-dependent glutamate production (Extended Data Fig. 2a ). Consequently, during conditions of glutamine depletion, cells cultured in 2i/L medium were able to use glucose-derived carbons to maintain elevated glutamate pools sufficient to support cell growth (Extended Data Fig. 2b ). Moreover, in comparison with their S/L counterparts, 2i/L cells used more glucose-derived carbon and relatively less glutamine-derived carbon to support protein synthesis (Extended Data Fig. 2c ), confirming that 2i promotes increased glucose-dependent amino acid synthesis.
Diminished glutamine entry into the TCA cycle, coupled with the observed efflux of glucose-derived carbons from the TCA cycle as glutamate, suggested that cells cultured in 2i/L might not be oxidizing all the aKG produced from glutamine in the mitochondria. Indeed, the aKG/succinate ratio was robustly elevated by 2i/L in every ES-cell line tested ( Fig. 3a ). Cellular aKG/succinate ratios have been implicated in the regulation of the large family of aKG-dependent dioxygenases 14 . As Jumonji C (JmjC)-domain-containing histone demethylases and the Tet family of DNA demethylases comprise a major subset of these enzymes, the elevated ratio of aKG/succinate observed in cells grown in 2i/L medium could have important implications for the regulation of chromatin structure.
Since aKG was largely derived from glutamine metabolism ( Fig. 2d ), we tested whether glutamine deprivation affected histone lysine methylations known to be regulated in part by aKG-dependent demethylases 15 . Cells cultured in glutamine-free medium exhibited increases in trimethylation and decreases in monomethylation on H3K9, H3K27, H3K36 and H4K20, whereas H3K4 methylations remained unchanged ( Fig. 3b ). DM-aKG reversed the increase in H3K27me3 and H4K20me3 observed in glutamine-deficient medium (Extended Data Fig. 3a ), confirming that these changes could be accounted for by the decline in glutamine-dependent 
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aKG. Treatment with GSK-J4 (ref. 16 ), a cell-permeable inhibitor that preferentially inhibits UTX and JMJD3, the two H3K27me3-specific JmjC-family histone demethylases ( Fig. 3c) , induced a dose-dependent increase in H3K27me3 with a concomitant reduction of H3K27me1 that was comparable in magnitude to the difference observed when cells were cultured in the presence or absence of glutamine ( Fig. 3b, d) .
These data indicate that the methylation of certain histone lysines, including H3K27, are actively suppressed by aKG-dependent histone demethylases in ES cells maintained in 2i/L medium.
In ES cells, 'bivalent domains' are developmentally regulated genomic regions characterized by the colocalization of H3K4me3 and H3K27me3 (refs 17-19) . Recent genome-wide analysis of H3K27me3 in S/L-and 2i/L-cultured ES cells revealed that H3K27me3 was specifically depleted at bivalent domain gene promoters in 2i/L-cultured cells 11 . Our data suggest that the observed increase in aKG might promote aKG-dependent H3K27me3 demethylation in 2i/L ES cells. Indeed, cells cultured in 2i/L exhibited a greater increase in H3K27me3 at bivalent domain promoters when incubated with the H3K27me3 demethylase inhibitor GSK-J4 than cells cultured in S/L ( Fig. 3e and Extended Data Fig. 3b, c) . The average fold change across the 14 bivalent promoters tested showed a highly significant increase in 2i/L-cultured ES cells compared with S/L-cultured ES cells (Fig. 3e ). Similarly, two independent cell lines with mutations in the Jumonji domain of the H3K27me3 demethylase JMJD3 (JMJD3 D/D -1 and JMJD3 D/D -2) (Extended Data Fig. 4a -c) demonstrated increases in H3K27me3 levels relative to control lines that were significantly elevated in cells cultured in 2i/L, reflecting enhanced demethylation at these loci in ES cells cultured in 2i/L ( Fig. 3f ). Furthermore, treatment with GSK-J4, but not the inactive isomer GSK-J5, increased the aKG/succinate ratio in cells cultured in 2i/L (Fig. 3g ). These results indicate that 2i/L rewires glutamine metabolism to maintain aKG pools favouring active demethylation of a variety of histone marks.
In addition to reduced H3K27me3 at bivalent domain promoters, cells cultured in 2i/L exhibit DNA hypomethylation 5,7-9 . Incubating cells with ascorbic acid, a cofactor for aKG-dependent dioxygenases, activates Tet-dependent gene expression and promotes DNA demethylation 20 . Therefore, we tested whether aKG treatment could exert similar effects (Extended Data Fig. 5a ). Total DNA methylation was reduced in cells cultured with cell-permeable aKG (Extended Data Fig. 5b ) and treatment with aKG, but not succinate, induced expression of innercell-mass-and germline-associated genes previously identified as targets of Tet-mediated activation (Extended Data Fig. 5c) 20, 21 . The effects of aKG persisted upon extended passaging (Extended Data Fig. 5d ) and were largely abrogated in Tet1/Tet2 double-knockout ES cells (Extended Data Fig. 5e ). These results suggest that intracellular aKG production may stimulate the activity of multiple aKG-dependent dioxygenases to regulate coordinately the epigenetic marks characteristic of naive pluripotency.
To test whether modulation of the aKG/succinate ratio can influence pluripotent cell fate decisions, we performed colony-formation assays with S/L-cultured ES cells in the presence of aKG or succinate. Colonies formed in S/L medium supplemented with DM-aKG (S/L1DM-aKG) had brighter AP staining and retained the compact colony morphology typical of undifferentiated ES cells ( Fig. 4a ). Although the total number of colonies was similar in all three conditions, the S/L1DM-aKG wells contained more than double the number of fully undifferentiated colonies compared with S/L only and S/L1DM-succinate ( Fig. 4b) . As a further test of the ability of aKG to promote maintenance of ES cells, we used a knock-in Nanog-green fluorescent protein (GFP) reporter line 22 and found that aKG was sufficient to enhance Nanog expression in a dose-dependent manner ( Fig. 4c and Extended Data Fig. 6 ). These results support the conclusion that aKG promotes the self-renewal of ES cells in vitro.
These data demonstrate that the cellular aKG/succinate ratio contributes to the ability of ES cells to suppress differentiation. The rewiring of cellular metabolism by inhibitors of GSK-3b and MAPK/ERK signalling results in a reprogramming of glucose and glutamine metabolism; in turn, this leads to accumulation of aKG and favours demethylation of repressive chromatin marks such as DNA methylation and H3K9me3, H3K27me3 and H4K20me3 (see Supplementary Discussion) . Future studies will investigate the mechanisms through which these inhibitors influence the nuclear/cytosolic accumulation of aKG derived from glucose and glutamine. While we cannot rule out chromatinindependent effects of aKG supplementation on ES cells, our results support the notion that chromatin in pluripotent ES cells is responsive to alterations in intracellular metabolism. Indeed, recent clonal analysis 
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of pluripotent cells revealed that DNA methylation is highly dynamic, balancing the antagonistic processes of removal and addition 23 . Together, these results suggest that continued elucidation of the interconnections between signal transduction and cellular metabolism will shed important light on stem cell biology, organismal development and cellular differentiation.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
Supplementary Information is available in the online version of the paper. 13 C] glutamine (Cambridge Isotope Laboratories) and either 20 mM unlabelled glucose or 2 mM unlabelled glutamine as necessary; all supplements were the same as in experimental media described above (S/L or 2i/L). All experiments were performed using feeder-free conditions. ESC-1 EpiSCs were cultured feeder-free on fibronectin (Sigma)-coated plates in EpiSC maintenance medium including DMEM/F12, N2 and B27 supplements, penicillin/streptromycin, 0.1 mM 2-mercaptoethanol, L-glutamine, 75 mg ml 21 BSA (Gibco) supplemented with human activin A (20 ng ml 21 ; Peprotech) and bFgf (10 ng ml 21 ; Invitrogen). EpiSCs were passaged 1:2 or 1:4 using Accutase every other day. For ES-cell to EpiSC differentiation, ESC-1 cells were plated onto fibronectin-coated dishes. Twenty-four hours after plating, the medium was changed to EpiSC maintenance medium supplemented with 6 mM JAK inhibitor (Calbiochem) for five passages. Analysis was performed on passage 7 EpiSCs. GSK-J4 and GSK-J5 were purchased from Tocris Bioscience. Teratomas. ESC-1 cells were plated in maintenance medium at a concentration of 2.5 3 10 5 cells per T25 dish. The following day medium was changed to 2i/L experimental medium with or without glutamine. 72 h later, 1 3 10 6 cells were harvested from each group and mixed 1:1 with experimental medium (without glutamine) plus Matrigel Basement Membrane Matrix (BD) or experimental medium alone and injected into the flanks of recipient SCID mice aged 8-12 weeks (NOD scid gamma JAX 005557 purchased from Jackson Laboratories). All conditions produced tumours in 4-8 weeks. Mice were euthanized before tumour size exceeded 1.5 cm in diameter. Tumours were excised and fixed in 4% paraformaldehyde overnight at 4 uC. Tumours were paraffin-embedded and sections were stained with haematoxylin and eosin according to standard procedures by Histoserv. Glucose, glutamine and lactate measurements. Glucose, glutamine and lactate levels in culture medium were measured using a YSI 7100 multichannel biochemistry analyser (YSI Life Sciences). Fresh medium was added to 12-well plates of sub-confluent cells and harvested 48 h later. Changes in metabolite concentrations relative to fresh media were normalized to the protein content of each well. These experiments were performed independently at least two times.
Metabolite profiling. For all metabolite experiments, cells were seeded in their standard culture medium in 6-well plates and the next day were changed into experimental medium. Medium was changed again at the indicated time before harvest (usually 1-24 h). Metabolites were extracted with 1 ml ice-cold 80% methanol supplemented with 20 mM deuterated 2-hydroxyglutarate (D-2-hydroxyglutaric-2,3,3,4,4-d 5 acid (d5-2HG)) as an internal standard. After overnight incubation at 280 uC, lysates were harvested and centrifuged at 21,000g for 20 min to remove protein. Extracts were dried in an evaporator (Genevac EZ-2 Elite) and resuspended by incubation at 30 uC for 2 h in 50 ml of 40 mg ml 21 methoxyamine hydrochloride in pyridine. Metabolites were further derivatized by addition of 80 ml of MSTFA plus 1% TMCS (Thermo Scientific) and 70 ml ethyl acetate (Sigma) and incubated at 37 uC for 30 min. Samples were analysed using an Agilent 7890A GC coupled to Agilent 5975C mass selective detector. The GC was operated in splitless mode with constant helium gas flow at 1 ml min 21 . One microlitre of derivatized metabolites was injected onto an HP-5MS column and the GC oven temperature ramped from 60 uC to 290 uC over 25 min. Peaks representing compounds of interest were extracted and integrated using MassHunter software (Agilent Technologies) and then normalized to both the internal standard (d5-2HG) peak area and the protein content of duplicate samples as determined by a BCA protein assay (Thermo Scientific). Ions used for quantification of metabolite levels are as follows: d5-2HG m/z 354; aKG, m/z 304; aspartate, m/z 334; glutamate, m/z 363; malate, m/z 335; and succinate, m/z 247. All peaks were manually inspected and verified relative to known spectra for each metabolite. For isotope tracing studies, experiments were set up as described earlier using glucose-and glutamine-free DMEM: NB media base supplemented with 12 C-glucose (Sigma) and 12 C-glutamine (Gibco) or the 13 a, Representative histogram of GFP intensity of Nanog-GFP cells treated with or without DM-aKG for 3 days. Grey represents background staining. b, ESC-1 cells were cultured in S/L medium with DM-aKG for four passages and then switched to medium containing the indicated amounts of DM-aKG (0.5-4 mM) or vehicle control (S/L) for 3 days. GFP expression (M.F.I.) was determined by fluorescence-activated cell sorting (FACS). Data are presented as the mean 6 s.d. of triplicate wells from a representative experiment.
